News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
Zepbound comes as a liquid solution inside prefilled, single-dose injection pens. It also comes in single-dose vials. Both forms are used to administer the drug as an injection under your skin.
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...
Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.
Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions. Jun. 16, 2025 6:45 AM ET Eli Lilly and Company (LLY) ...
DoseSpot, which delivers best-in-class e-prescribing, insurance verification and revenue cycle management solutions for healthcare providers, announced today the results of a new data analysis on 102, ...
With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499 /month or less, regardless of insurance status, under Zepbound Self Pay ...
Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions Provided by PR Newswire Jun 16, 2025, 10:45:00 AM ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results